Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

58-61-7

Adenosine

58-61-7
342821-66-3

4-Acetamido-D3-antipyrine

342821-66-3
23893-13-2

Anhydro Erythromycin A

23893-13-2
330784-47-9

Avanafil

330784-47-9
77337-73-6

Acamprosate Calcium

77337-73-6
123-30-8

4-Aminophenol

123-30-8
329-65-7

DL-Adrenaline

329-65-7
22862-76-6

Anisomycin

22862-76-6
103129-82-4

(S)-Amlodipine

103129-82-4
1951-25-3

Amiodarone

1951-25-3
2835-68-9

4-Aminobenzamide

2835-68-9
19406-86-1

3-Amino-4-methylbenzamide

19406-86-1
89796-99-6

Aceclofenac

89796-99-6
67014-36-2

5-Amino-6-methyl benzimidazolone

67014-36-2
652-37-9

Acefylline

652-37-9
8048-52-0

Acriflavin Technical

8048-52-0
06/02/6301

1-Aminoimidazolidine-2,4-dione

06/02/6301
8063-24-9

Acriflavin HCl

8063-24-9
106685-40-9

Adapalene

106685-40-9
41294-56-8

Alfacalcidol

41294-56-8